Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
Silvia Moga, Andreea Teodorescu, Petru Ifteni, Claudia Gavris, Paula-Simina Petric Faculty of Medicine, Transilvania University of Brasov, Brasov, RomaniaCorrespondence: Petru IfteniFaculty of Medicine, Transilvania University of Brasov, Romania, 29th Eroilor Boulevard, Brasov, 500036, RomaniaTel +4...
Main Authors: | Moga S, Teodorescu A, Ifteni P, Gavris C, Petric PS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/inflammatory-response-in-sars-cov-2-infection-of-patients-with-schizop-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Schizophrenia long-acting antipsychotics initiation index (SLAAII)
by: P. Ifteni, et al.
Published: (2021-04-01) -
Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
by: Ana Aliana Miron, et al.
Published: (2023-01-01) -
Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)
by: Petru Ifteni, et al.
Published: (2021-12-01) -
Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection
by: Moga S, et al.
Published: (2022-05-01) -
Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania
by: Ana A. Miron, et al.
Published: (2022-07-01)